Intelligence Synthesis · April 6, 2026
Research Brief
Investigation: Palantir Technologies — "UK Parliament's Public Accounts Committee has examined value-for-money…"

Inference Investigation

Claim investigated: UK Parliament's Public Accounts Committee has examined value-for-money aspects of government technology contracts including those involving Palantir Entity: Palantir Technologies Original confidence: inferential Result: STRENGTHENED → SECONDARY

Assessment

The claim is partially accurate but imprecise. The UK Public Accounts Committee (PAC) has examined NHS digitisation and data management where Palantir contracts feature, but PAC's primary remit is NHS value-for-money rather than 'government technology contracts' broadly. The established facts confirm PAC examined Palantir's NHS role (Fact #16), but the inference conflates health-sector scrutiny with broader technology procurement oversight, which falls more to the Digital, Culture, Media & Sport Committee or Defence Committee for non-health contracts.

Reasoning: Established Fact #16 directly confirms PAC examined Palantir's NHS data management role in 2022-2023. However, the claim's broader framing ('government technology contracts including those involving Palantir') overstates the scope. PAC's published inquiries focused specifically on NHS data systems (COVID-19 Data Store, Federated Data Platform) rather than cross-government technology procurement. The claim is substantively correct for NHS contracts but cannot be elevated to primary confidence without identifying specific PAC report citations naming Palantir in value-for-money findings.

Underreported Angles

  • The PAC's 2023 inquiry into NHS England's procurement of the Federated Data Platform raised concerns about single-supplier dependency and contract negotiations, but specific cost-effectiveness analysis of Palantir's pricing versus alternatives was not publicly detailed
  • The distinction between PAC scrutiny (which occurred) and NAO audit findings (which would provide the evidentiary basis) has been conflated in coverage - the NAO's actual value-for-money assessments of NHS data contracts may contain more granular findings than PAC oral evidence sessions
  • Palantir's NHS contracts evolved from emergency COVID-era arrangements (initially £1) to commercial terms - the transition pricing and whether competitive tendering occurred received limited parliamentary attention relative to data protection concerns
  • Cross-committee jurisdiction gaps: MoD's separate Palantir contracts (£240M referenced in entity description) appear not to have received equivalent PAC scrutiny, suggesting defence procurement escaped the health-sector transparency demands

Public Records to Check

  • parliamentary record: Public Accounts Committee Palantir site:parliament.uk Would confirm specific PAC sessions, reports, or evidence sessions where Palantir was named in value-for-money context

  • parliamentary record: Hansard 'Public Accounts Committee' 'Palantir' 2022 OR 2023 Would identify oral questions or debates referencing PAC findings on Palantir contracts

  • other: National Audit Office NHS data Palantir Federated Data Platform NAO reports provide the evidentiary foundation for PAC inquiries; would reveal specific value-for-money assessments

  • parliamentary record: Written questions Palantir 'value for money' site:parliament.uk Would identify specific ministerial responses quantifying contract values and justifications

  • other: Contracts Finder Palantir NHS England UK government procurement portal would show contract values, terms, and whether competitive tendering occurred

  • Companies House: Palantir Technologies UK Limited annual accounts Would reveal UK-specific revenue figures that could be cross-referenced against disclosed contract values

Significance

SIGNIFICANT — Parliamentary scrutiny of major government technology contracts establishes the public accountability record for surveillance and data infrastructure spending. The distinction between health-sector oversight (which occurred) and defence/security procurement oversight (apparently absent) reveals asymmetric transparency in how Palantir's UK government relationships are examined. This matters for assessing democratic accountability over intelligence-adjacent contractors.

← Back to Report All Findings →